In June, Gusu City is the most pleasant time of the year, with neither cold nor hot temperatures.

Under Building B of the First Hospital of Gusu City, Xu Xiu, director of the Laboratory Department and Li Jinyun, deputy director, were leading several young doctors from the laboratory department to stand outside the building, their bodies were shining warmly by the sun. While enjoying the warm sunbath, they kept looking at the hospital gate, as if they were waiting for someone.

Waiting a little bored, Xu Xiu chatted and said to Li Jinyun: "Have you watched "Nature" yesterday? Ruikang Medical has made a big splash."

On the cover of the new issue of "Nature" yesterday, there was a photo of a big hematopoietic stem cell. The front-page paper was headlined by Erlos Research Center, and Chen Changan and Yun Heng and other researchers involved in the induction of hematopoietic stem cell projects.

"On the Practical Application of Inducing Hematopoietic Stem Cell Technology"

In addition, this issue of "Nature" even published three papers from the Erlos Research Center in one go, the other two are "Clinical Application of C-myc Gene" and "Reprogramming of Hematopoietic Stem Cell Genes"!

These three papers are tantamount to dropping a bombshell in the global biology academic circle!

In particular, some scientific research teams and research institutions in Japan and Europe who have been conducting in-depth research on the field of inducing hematopoietic stem cells for more than ten years have downloaded the electronic version of these three papers as soon as possible, reading them eagerly, hoping to find out how Chen Changan achieved the feat of artificial hematopoietics!

However, although the discussions in these three papers are already very powerful, it can even be said to provide all researchers with a mature technology to artificially induce the conversion of hematopoietic stem cells into blood cells.

However, even if other scientific research institutions can restore this technology in the laboratory according to the methods in the paper, they still cannot commercialize it and mass production.

Because this involves the manufacturing technology of artificial hematopoietic equipment, Chen Changan has covered the relevant technologies in this regard tightly, especially the parameters and principles of the core induced rays, which are even more secret. Even if outsiders dismantle the machine and reversely produce the ray generation device, they cannot figure out which rays play the inducing role.

But at least through the paper published by the Erlos Research Center, research institutions in other countries can achieve mature laboratory-stage artificial blood cell production.

I guess if I give them ten or eight years, I still have hope of commercializing them.

However, commercial competition will slow down step by step. Ten or eight years later, the global artificial hematopoietic equipment market has long been occupied by Ruikang Medical. At this time, other medical equipment companies want to enter the market, and the daylily will be cold.

If latecomers want to knock down Ruikang Medical, which has already occupied the market, they will probably have to pay ten times or even more than Ruikang, to have a slight hope.

So Chen Changan was not panicked at all.

After five or six years, after other medical companies are about to overcome the manufacturing technology of artificial hematopoietic equipment, Chen Changan will register the patent. An artificial hematopoietic equipment involves at least hundreds of exclusive patents. This layer of patent barrier alone is enough for latecomers to drink!

Of course, the recent papers released by the Erlos Research Center are not only these three. Since the laboratory work of the hematopoietic stem cell project was over, the group of researchers under Yun Heng have been working on editing the papers.

There are seven or eight papers related to hematopoietic stem cells alone. In addition, there are some papers related to gene reprogramming and blood cells that add up to about twenty papers.

Most of these papers are published in some sub-journals of Nature involving biology, such as Nature-Microbiology, and some biology series of journals in Science.

For a moment, the Erlos Research Center immediately became an authoritative scientific research institution in hematopoietic stem cells, and even the same was true in gene reprogramming.

Most of the first authors of these papers are ranked by Chen Changan and Yun Heng. Although they did not participate in the paper writing work, as the project leader and the main R&D force, they are ranked by the first authors without any doubt.

In addition, Chen Changan also served as the corresponding author. After all, he is the head and boss of Erlos Research Center, and no one is more suitable than him.

Ren Xingyi, the former head of the biology group of the Bai Bingchun Institute, who contributed only to Chen Changan and Yun Heng, ranked second in the author.

The other researchers in the project team were not ignored. As long as the researchers who participated in the research on the hematopoietic stem cell project were sorted according to their contribution to the project.

The greater the contribution to the project, the higher the ranking. More than 30 scientific researchers in the entire project team have been famous in the papers and published them in the Elos Research Center.

After learning about this news, Chen Changan felt a little regretful that if he was a graduate student who was studying for a master's degree or a doctorate, as the first author, he would probably be able to graduate directly.

Unfortunately, he is just an undergraduate dog.

............

His eyes turned back to the First Hospital of Gusu City.

After hearing Xu Xiu's words, Li Jinyun smashed his mouth and said with some sigh: "Mr. Chen is afraid he will take Nobel this time, right?"

"The biology community should not have had a more sensational breakthrough in biology than the implementation of hematopoietic stem cell technology in the past two years, right?"

I'm using the book-chasing app I've been using recently, [\Mimi\Reading\app\\] cache reading and read offline!

Xu Xiu nodded and said with certainty: "There has not been any major breakthrough in biology and medicine in the past two years. If nothing unexpected happens, next year's Nobel Prize in Physiology or Medicine should be in the hands of President Chen, so there will be no suspense."

Not to mention anything else, just the success of inducing hematopoietic stem cell technology is enough to obtain Nobel. It can almost be considered a foregone conclusion and there is no room for discussion.

The two of them just sighed that they didn't think that Chen Changan was not qualified to win the award. If Karolinska Academy does not award the Nobel Prize in Physiology or Medicine to Chen Changan and his scientific research team next year, I'm afraid the fairness of the Nobel Prize will be questioned!

"Hey, after Academician Tu, another local scientist who won the Nobel Prize in Medicine will appear in our country. But is Chen finally a scientist?" Li Jinyun joked with a smile.

Xu Xiu was confused when he asked this. In the eyes of the staff of the First Hospital of Gusu, Chen Changan's image as a businessman and an entrepreneur was obviously more deeply rooted in the hearts of the people.

Suddenly linking the three words "scientists" with Chen Changan did make them feel a little uncomfortable.

However, Xu Xiu soon reacted and frowned and said, "Since Mr. Chen has led the research and development of the entire hematopoietic stem cell project, he is naturally an excellent scientist. Lao Li cannot judge heroes by his academic qualifications. Although Mr. Chen is not a master of a great professor, his scientific research level is strong! He is a great master!"

Li Jinyun smiled and shook his head. He was just joking, without any malice, nor did he mean to question Chen Changan. However, Xu Xiu has always been more rigorous and took his jokes seriously.

Both of them have been working together for more than ten years, so he naturally knew Xu Xiu's temper and immediately shut up, without any intention of explaining more.

Just then, a medium-sized bus with a big red cross printed on the body slowly drove into the hospital gate. Li Jinyun immediately raised his hand and pointed to the car and said, "Director Xu, the car from the blood center is here and is ready to start work!"

Xu Xiu looked at it and saw the bus coming towards them. Then he hurriedly greeted the young doctors from other departments and said: "Today, the blood center transported the first batch of artificial red blood cell products. Although it was artificially produced, it was no different from ordinary red blood cell products. How to deal with blood products normally, it will be done in a while, and everything will be the same!"

"There are a total of 100 liters of red blood cell products, which are prepared for a large number of severe thalass patients that our hospital will receive next. They cheered me up and did a good job in the storage management!"

"Although our laboratory department will be in a busy period in the next period of time, even so, no work mistakes are allowed! If anyone makes such a low-level mistake that makes the blood bag confused, not only will he get out of here, but he will also have to go to a medical lawsuit. He will think carefully in his heart about the consequences!"

After Xu Xiu fiercely intimidated the young doctors under his command, he looked around them and shouted in a serious tone: "Did you hear them clearly?"

All the doctors present at the scene replied with great vitality and loud voice: "I heard it clearly!"

Xu Xiu nodded with satisfaction: "Okay, very energetic!"

Just then, the car in the blood center had already driven downstairs of Building B and stopped in front of Xu Xiu and his group.

"Get on the car and unload the goods!"

With Xu Xiu's order, all the doctors in the laboratory began to get busy in an orderly manner. According to different blood types, the red blood cell products on the vehicle were transported into the blood product storage cabinet of the laboratory.

These two low-temperature storage cabinets with super large capacity in the department were newly purchased last week. Where can I use large low-temperature storage cabinets with a capacity of up to 200 liters in the first hospital in Gusu?

That is, Fu, who was launched by artificial hematopoietic equipment, only changed to two large low-temperature storage cabinets in the laboratory department, for today!

After moving for about ten minutes, all the 100 liters of blood products were properly placed in the low-temperature storage cabinet according to different blood types.

Xu Xiu also signed his name on the form handed over by the staff of the Blood Center.

After signing the autograph, he still asked: "When will the next batch of red blood cell products be delivered?"

The staff put away the supply form and said to Xu Xiu with a smile: "Director Xu, there will be a batch of 100 liters of red blood cell suspension tomorrow. If your hospital is used up, just apply to the blood center. You can give you as much as you want. Don't worry, use it boldly and it's all done!"

After saying a word, he quickly started the car and turned around and left the First Hospital of Gusu City.

Only Xu Xiu was left with a look of surprise and suspicion.

There are still 100 liters tomorrow, just apply after using them? How much can you give away as much as you want?

This feeling of achieving red blood cell freedom is really good!

At this moment, Xu Xiu's heart was in a state of great excitement, and thousands of thoughts finally turned into one sentence.
Chapter completed!